Gilead Sciences Opens New Research Center in Foster City to Accelerate Biomedical Innovation Gilead Sciences, Inc. (Nasdaq: GILD) has officially opened a new 182,000-square-foot Research Center at its headquarters in Foster City, California, marking a significant expansion of the company’s…
Endeavor BioMedicines Reports Positive Quantitative Imaging Results for Taladegib in Idiopathic Pulmonary Fibrosis Endeavor BioMedicines, a clinical-stage biotechnology company focused on developing medicines with the potential to deliver transformational benefits to patients with life-threatening diseases, has announced new quantitative imaging…
Coya Therapeutics Publishes Preclinical Findings for COYA 303 in Neuroinflammation Coya Therapeutics, Inc. (NASDAQ: COYA), a clinical-stage biotechnology company focused on developing biologic therapies designed to enhance regulatory T-cell (Treg) function, has announced the publication of new preclinical findings evaluating…
Compass Pathways to Highlight Treatment-Resistant Depression Research and Launch New HCP Education Campaign at Psych Congress 2026 Compass Pathways plc (Nasdaq: CMPS), a biotechnology company focused on developing new treatment options for mental health conditions, has announced its participation in…
Alzheon Reports Biomarker Findings Supporting Potential Disease-Modifying Effects of Valiltramiprosate in Early Alzheimer’s Disease Alzheon, Inc., a clinical-stage biopharmaceutical company focused on developing investigational therapies and diagnostic assays for Alzheimer’s disease (AD) and other neurodegenerative disorders, has announced the peer-reviewed…
Agilent Launches S540MD Slide Scanner in the U.S. Following FDA Clearance Agilent Technologies Inc. has announced the U.S. launch of the Agilent S540MD Slide Scanner System, a whole slide imaging (WSI) digital scanner designed to support high-throughput digital pathology workflows.…
eGenesis Reports Sustained Kidney Function and Successful Human Transplantation Following Genetically Engineered Pig Kidney Transplants eGenesis, a biotechnology company focused on developing genetically engineered organs designed for transplantation into humans, has announced encouraging clinical updates from its ongoing Expanded Access…
SinglePass Biopsy Closure Device Demonstrates 100% Technical Success and No Clinically Significant Bleeding in Multicenter Study SinglePass, Inc., developer of the SinglePass biopsy closure device, has announced the publication of new multicenter clinical data evaluating the safety and effectiveness of…
Lōkahi Therapeutics Expands ai² Futures Lab Through New Partnership With San Diego State University Lōkahi Therapeutics™, a subsidiary of Glucotrack, Inc. (Nasdaq: GCTK), has announced a new collaboration with San Diego State University’s (SDSU) Fowler College of Business, expanding the…
Thermo Fisher Scientific Launches Multiskan Ease Absorbance Microplate Reader for Routine Laboratory Applications Thermo Fisher Scientific has announced the launch of the Thermo Scientific™ Multiskan™ Ease Absorbance Microplate Reader, a new single-mode absorbance microplate reader designed to support a broad…
Rapalogix Health Expands Research Capabilities with New Laboratory at Princeton Innovation Center BioLabs Rapalogix Health, a biotechnology company focused on developing longevity-based approaches to skin health, has announced the establishment of dedicated laboratory space at Princeton Innovation Center BioLabs in…
Scholar Rock Advances Apitegromab Development for FSHD with FDA Fast Track and Orphan Drug Designations Scholar Rock (NASDAQ: SRRK), a global biopharmaceutical company focused on developing therapies for rare, severe, and debilitating neuromuscular diseases, has announced important regulatory and clinical…